Company
Antengene Therapeutics Limited
Antengene Therapeutics Limited has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| ATG-037 | Phase 1 | Locally Advanced or Metastatic Solid Tumors |
Latest
No recent events.
Follow Antengene Therapeutics Limited on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.